Linnea launches low-dose, high-bioavailability lignans
Swiss manufacturer Linnea has signed a license agreement to introduce Hormos Medical Corporation's spruce-derived HMRlignan ingredient to the worldwide dietary supplements market, reports Jess Halliday.